Inbios International, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 4, 2027The maintenance fee for Neutralizing antibody immunoassays (US 11,693,011) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens (US 11,913,953) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 21, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,173,383 | Methods and materials for the detection of Leishmania infection In force · USPTO record | In force | USPTO record | |
| US 8,399,261 | Lateral flow assay system and methods for its use In force · USPTO record | In force | USPTO record | |
| US 9,989,530 | Methods and materials for the detection of dengue virus infection In force · USPTO record | In force | USPTO record | |
| US 8,920,804 | Methods and Materials for the Detection of Dengue Virus Infection In force · High confidence | In force | High confidence | |
| US 10,955,414 | Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens In force · USPTO record | In force | USPTO record | |
| US 11,913,953 | Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens In force · USPTO record | In force | USPTO record | |
| US 12,145,153 | Lateral flow assay cassette In force · USPTO record | In force | USPTO record | |
| US 11,693,011 | Neutralizing antibody immunoassays In force · USPTO record | In force | USPTO record | |
| US 12,014,490 | Systems and methods of validation of rapid test device results In force · USPTO record | In force | USPTO record | |
| US 12,249,407 | Systems and methods of validation of rapid test device results with enhanced image capture In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 11: 2 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 4 no status recorded